RUBELLA ANTIBODY POSITIVE

RUBELLA ANTIBODY POSITIVE was reported 57 times

RUBELLA ANTIBODY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Dopamine-2 Receptor Antagonist [EPC] 11 0.0014
1 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
2 Sphingosine 1-phosphate Receptor Modulator [EPC] 1 0.0001
3 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
4 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
5 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
6 Interferon beta [EPC] 4 0.0000
7 Purine Antimetabolite [EPC] 2 0.0000
8 Macrolide Antimicrobial [EPC] 1 0.0000
9 Corticosteroid [EPC] 18 0.0000
10 Arteriolar Vasodilator [EPC] 1 0.0000
11 Janus Kinase Inhibitor [EPC] 2 0.0000
12 Prostaglandin Analog [EPC] 1 0.0000
13 Aminosalicylate [EPC] 1 0.0000
14 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
15 Mood Stabilizer [EPC] 2 0.0000
16 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
17 Anti-epileptic Agent [EPC] 2 0.0000
18 Proteasome Inhibitor [EPC] 1 0.0000
19 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
20 Vitamin D [EPC] 2 0.0000
21 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
22 Vitamin B12 [EPC] 2 0.0000
23 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
24 Vitamin C [EPC] 2 0.0000
25 Alkylating Drug [EPC] 1 0.0000
26 Retinoid [EPC] 1 0.0000
27 Progestin [EPC] 1 0.0000
28 Osmotic Laxative [EPC] 1 0.0000
29 beta-Adrenergic Blocker [EPC] 1 0.0000
30 Benzodiazepine [EPC] 2 0.0000
31 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
32 Insulin Analog [EPC] 1 0.0000
33 Thalidomide Analog [EPC] 1 0.0000
34 Kinase Inhibitor [EPC] 1 0.0000
35 Platelet Aggregation Inhibitor [EPC] 1 0.0000
36 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
37 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000